| Revenue | DKK -7,3M | -233% |
| EBITDA | DKK -7,3M | -233% |
| Net profit | DKK -6,3M | -292% |
| Total assets | DKK 33,7M | -13% |
| Equity | DKK -1,7M | -138% |
| Employees | 11 | — |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 1.736 | 5.491 | -7.282 |
| Staff expenses | -0 | -0 | -0 |
| EBITDA | 1.736 | 5.491 | -7.282 |
| Depreciation & amort. | -0 | -0 | -0 |
| EBIT | 1.736 | 5.491 | -7.282 |
| Net financials | -624 | -1.515 | -609 |
| Profit before tax | 1.111 | 3.975 | -7.891 |
| Tax | 200 | 682 | -1.551 |
| Net profit | 911 | 3.294 | -6.340 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 38.401 | 38.815 | 33.684 |
| Equity | 1.311 | 4.605 | -1.734 |
| Long-term debt | 28.870 | 28.304 | 28.304 |
| Short-term debt | 3.432 | 437 | 3.199 |
| Total debt | 32.302 | 28.741 | 31.504 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MW Management | Management | 2026 | — | — |
JS Management | Management | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Deputy Chairman | 2025 | — | — | |
| Chairman | 2022 | — | — | |
| Chairman | 2026 | — | — | |
| Deputy Chairman | 2026 | — | — | |
| Chairman | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Danish Genetics Holding ApS | Company | 100.0% | 100.0% | 2025 |
| Person | Role here | Other companies |
|---|---|---|
| Mikael Wædeled Sigvardsen | Management | 0 companies |
| Jørgen Salhøj Rask | Management | 0 companies |
| Elisabeth Salhøj Rask | Board of Directors | 0 companies |
| Niels Henrik Reventlow | Deputy Chairman | 0 companies |
| Nikolaj Salhøj Rask | Chairman | 0 companies |
| Steen Agerbo Bødtker | Chairman | 0 companies |
| Mads Hans Kring | Deputy Chairman | 0 companies |
| Rafael Jacobus Henri Gerard Beeren | Chairman | 0 companies |